Navigation Links
FluMist(R) Begins Shipping for 2009-2010 Influenza Season
Date:7/28/2009

GAITHERSBURG, Md., July 28 /PRNewswire/ -- MedImmune announced today that it has begun shipping its seasonal influenza vaccine FluMist((R) )(Influenza Vaccine Live, Intranasal) to vaccine distributors who service health care providers throughout the United States. MedImmune expects approximately 10 million doses of its trivalent (three-strain) nasal spray flu vaccine will be available for the 2009-2010 influenza season through a variety of private health care practices, public health departments, school-based vaccination programs, military bases, and other locations.

The U.S. Centers for Disease Control and Prevention (CDC) and American Academy of Pediatrics advise that flu vaccine be administered every year as soon as it becomes available. A MedImmune analysis suggests that starting influenza vaccination in August instead of October may help reach an additional 11.5 million children at already-scheduled healthcare provider visits.

The 2009-2010 influenza season is the first for full implementation of the recommendations by the CDC's Advisory Committee on Immunization Practices (ACIP) that children six months through the age of 18 years be vaccinated annually against influenza, meaning 30 million additional children 5 through 18 years of age now fall within influenza vaccination recommendations.

"MedImmune is committed to delivering our seasonal nasal spray influenza vaccine in the summer months in order to increase opportunities for vaccination," said Alex Zukiwski, MD, MedImmune's Executive Vice President, Clinical Research & Chief Medical Officer. "If more eligible children can be vaccinated against seasonal influenza while attending back-to-school checkups, sports physicals, and clinics early in the school year, the country will be better prepared for the flu season ahead."

FluMist is available in every state through the feder
'/>"/>

SOURCE MedImmune
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related biology technology :

1. DOV Pharmaceutical, Inc. Begins Trading on OTC Bulletin Board
2. Genzyme Begins Major Expansion of Boston Manufacturing Facility
3. Medical Services Begins Working With United States Companies for Distribution of Its Products
4. Phlo Affiliate Begins Roll Out to Metropolitan New York City Account Base
5. Care to Care Begins Providing Radiology Benefit Management Services to Touchstone Health
6. SPO Medical Begins Shipping PulseOx 6000(TM) and PulseOx 6100(TM)
7. Aeterna Zentaris Begins Second Phase 3 Trial of Cetrorelix for Benign Prostatic Hyperplasia
8. Ohio Task Force Begins Mission of Creating a New 21st Century Industry
9. Thomson Scientific Begins Expansion of Web of Science
10. Nikon Instruments Begins Direct Sales and Technical Support in Southern California and Rocky Mountain Territories
11. CardioDynamics Shareholders Approve One-for-Seven Reverse Split of Companys Common Stock and Trading in Post-split Shares Begins May 9, 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... (PRWEB) May 23, 2013 Patheon ... manufacturing services to the global pharmaceutical industry, will host ... Novel Approaches to Testing” on Tuesday, June 4, 2013 ... pharmaceutical manufacturers are required to comply with regulations for ... practices with limited scientific underpinning and little evaluation of ...
(Date:5/23/2013)... SAN MARINO, Calif. , May 23, 2013 ... announces today a strategic alliance with DAK Renewable ... increase the corn oil yield. VG Energy is ... Inc. (OTC Pink: VGLS). VG Energy,s ... pathways to increase the oil yield in plants, ...
(Date:5/23/2013)... Z Trim Holdings, Inc. (OTC Markets: ZTHO), ... of industries, announced that Chef Erin Ryan ... year,s National Restaurant Association ("NRA") NRA Show, which was ... Research Chefs Association.  Chef Ryan spoke on the subject ... and the Ugly," joining four other prestigious panelists including: ...
(Date:5/23/2013)... During the conduct of research involving ... principles of good clinical practice (GCP) and human ... Lim, Fellow, Clinical Development at Novartis Pharmaceuticals, will ... the International Conference on Harmonization (ICH) Guideline for ... the conduction of clinical trials ,     Apply ...
Breaking Biology Technology:Patheon to Present on “Cleaning Validation: Science, Risk and Novel Approaches to Testing” 2VG Energy Enters into a Strategic Alliance with DAK Renewable Research for LipidMax Field Trials 2VG Energy Enters into a Strategic Alliance with DAK Renewable Research for LipidMax Field Trials 3Z Trim's Chef Erin Ryan sits on Expert Panel at NRA Show 2Z Trim's Chef Erin Ryan sits on Expert Panel at NRA Show 3Adhering to Good Clinical Practice, New Webinar Hosted by Xtalks 2
... Oct. 31, 2011 Azantis launches today AstaKrill™ , ... , a leading krill oil manufacturer, markets AstaKrill to resellers. ... that gives krill its distinct red color. The astaxanthin dosage ... other krill oils currently on the market. ...
... 31, 2011 Reportlinker.com announces that ... available in its catalogue: ... Analysis, Opportunity Assessment and Market Forecasts ... http://www.reportlinker.com/p0317992/Spinal-Implants---Global-Pipeline-Analysis-Opportunity-Assessment-and-Market-Forecasts-to-2016.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Medical_Devices Spinal Implants ...
... , Spherix Incorporated (NASDAQ: ... in diabetes, metabolic syndrome and atherosclerosis, and providers of ... and pharmaceutical companies – today announced the closing of ... of its common stock together with warrants to purchase ...
Cached Biology Technology:AstaKrill™ the Best Krill Oil Boosts Astaxanthin 2Spinal Implants - Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016 2Spinal Implants - Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016 3Spinal Implants - Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016 4Spinal Implants - Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016 5Spinal Implants - Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016 6Spinal Implants - Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016 7Spinal Implants - Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016 8Spinal Implants - Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016 9Spinal Implants - Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016 10Spherix Announces Closing of Private Placement of $1.25 Million, Discusses Use of Proceeds 2Spherix Announces Closing of Private Placement of $1.25 Million, Discusses Use of Proceeds 3
(Date:5/22/2013)... cell powered buses, including a team from Simon ... processes and bus membrane durability. , The team ... in the operating cycle of the bus on ... study, led by SFU graduate student Natalia MaCauley, ... Burnaby-based Ballard Power Systems and funded by Automotive ...
(Date:5/22/2013)... genetic engineering drastically reduces the time and effort ... workhorses of biotechnology, scientists are reporting. Published in ... method paves the way for more rapid development ... and other activities. , Keith Shearwin and colleagues ... the genetic material DNA into a bacterium,s genome ...
(Date:5/22/2013)... important new details on how climate change will affect ... in the Journal of Animal Ecology . This ... and informing policymakers of how species are likely to ... is a growing recognition among biologists that climate change ... that this is going to have very important consequences ...
Breaking Biology News(10 mins):Tests lead to doubling of fuel cell life 2UCLA life scientists present new insights on climate change and species interactions 2UCLA life scientists present new insights on climate change and species interactions 3UCLA life scientists present new insights on climate change and species interactions 4UCLA life scientists present new insights on climate change and species interactions 5
... more of the arteries in the lungs, including detecting ... may have little impact on the patient's outcome, a ... with suspected pulmonary embolism. About half of the patients ... had a single-detector CT examination. The radiology examinations came ...
... created the first active vaccine that can significantly delay and ... that is similar to mad cow disease. The new findings, ... a platform for the development of a vaccine to prevent ... particles called prions. , Although no cure for these diseases ...
... that allows immune cells known as neutrophils to protect ... at Washington University School of Medicine in St. Louis ... the development of an arthritis-like disorder by making the ... newly identified role for the gene, Foxo3a, may open ...
Cached Biology News:Newer imaging techniques may lead to over-treatment 2Active Vaccine Prevents Mice From Developing Prion Disease 2Active Vaccine Prevents Mice From Developing Prion Disease 3Disabling gene defuses rheumatoid arthritis in mice 2Disabling gene defuses rheumatoid arthritis in mice 3
Peptide-affinity Purified Polyclonal Antibody to ICEBERG Peptide with sequence EEDPQLASKMGLH, from C Terminus of the protein sequence according to NP_067546...
3T3 cells (RSV-transformed) Source: Cell Lysate Form: Ready to Use Application: Western Blotting Control...
A431 cells stimulated with EGF Source: Cell Lysate Form: Ready to Use Application: Western Blotting Control...
Molecular Biological Resources offers bulk quantities of existing protein products. Please see the Chimerx divisions website for existing products and contact lloconne@molbiores.com for pricing....
Biology Products: